Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001818382-25-000015
Filing Date
2025-01-23
Accepted
2025-01-23 16:34:03
Documents
1
Period of Report
2025-01-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1737668036.html 4  
1 FORM 4 wk-form4_1737668036.xml 4 3935
  Complete submission text file 0001818382-25-000015.txt   5475
Mailing Address 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713
Business Address 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713 919-313-9633
Humacyte, Inc. (Issuer) CIK: 0001818382 (see all company filings)

EIN.: 851763759 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 1160 HEDGEROW DRIVE GARNET VALLEY PA 19060
Business Address
Parikh Shamik J (Reporting) CIK: 0001916853 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39532 | Film No.: 25550585